Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Genome-Wide Knockout Screen in Human Macrophages Identified Host Factors Modulating Salmonella Infection. | mBio | 2019 | 31594818 | PubTator, text mining | PubMed |
| Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children. | Children (Basel) | 2019 | 31590274 | PubTator, text mining | PubMed |
| Correction: Keratinocyte differentiation promotes ER stress-dependent lysosome biogenesis. | Cell Death Dis | 2019 | 31582726 | PubTator, text mining | PubMed |
| Hydrangenol Isolated from the Leaves of Hydrangea serrata Attenuates Wrinkle Formation and Repairs Skin Moisture in UVB-Irradiated Hairless Mice. | Nutrients | 2019 | 31581754 | PubTator, text mining | PubMed |
| Modulation of the Lipid Profile of Reconstructed Skin Substitutes after Essential Fatty Acid Supplementation Affects Testosterone Permeability. | Cells | 2019 | 31557890 | PubTator, text mining | PubMed |
| Type XVIII Collagen Modulates Keratohyalin Granule Formation and Keratinization in Oral Mucosa. | Int J Mol Sci | 2019 | 31554264 | PubTator, text mining | PubMed |
| Low-Dose Naltrexone-Induced Remission in Hailey-Hailey Disease Maintained in Remission with Topical Combination of Ketamine and Diphenhydramine. | Indian Dermatol Online J | 2019 | 31544078 | PubTator, text mining | PubMed |
| Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. | Cells | 2019 | 31540162 | PubTator, text mining | PubMed |
| Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge. | PLoS Pathog | 2019 | 31525249 | PubTator, text mining | PubMed |
| Poncirus Trifoliata (L.) Raf. Extract Inhibits the Development of Atopic Dermatitis-like Lesions in Human Keratinocytes and NC/Nga mice. | Int J Med Sci | 2019 | 31523174 | PubTator, text mining | PubMed |
| Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols. | Sci Rep | 2019 | 31519952 | PubTator, text mining | PubMed |
| A human skin model to evaluate the protective effect of compounds against UVA damage. | Int J Cosmet Sci | 2019 | 31512246 | PubTator, text mining | PubMed |
| Water-Soluble Fullerenol C60(OH)36 toward Effective Anti-Air Pollution Induced by Urban Particulate Matter in HaCaT Cell. | Int J Mol Sci | 2019 | 31480310 | PubTator, text mining | PubMed |
| Treatment with Docosahexaenoic Acid Improves Epidermal Keratinocyte Differentiation and Ameliorates Inflammation in Human Keratinocytes and Reconstructed Human Epidermis Models. | Molecules | 2019 | 31480216 | PubTator, text mining | PubMed |
| Xenobiotic Receptors and Their Mates in Atopic Dermatitis. | Int J Mol Sci | 2019 | 31470652 | PubTator, text mining | PubMed |
| Protein biomarkers of neural system. | J Otol | 2019 | 31467504 | PubTator, text mining | PubMed |
| Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. | Cancer Sci | 2019 | 31444923 | PubTator, text mining | PubMed |
| Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function. | Int J Mol Sci | 2019 | 31438472 | PubTator, text mining | PubMed |
| LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors. | Cell Rep | 2019 | 31433976 | PubTator, text mining | PubMed |
| Microfluidics-based skin irritation test using in vitro 3D angiogenesis platform. | APL Bioeng | 2019 | 31431937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=66